News

Candidates who took the entrance test can now check their scores by using their Application Number ... Phase 1 registration can register for Phase II registrations . Registrations for KIITEE Phase ...
Iadademstat, a selective LSD1 inhibitor, is being tested with immune checkpoint inhibitors for extensive-stage SCLC in a phase 1/2 trial. The trial ... the immune system and to boost significantly the ...
TLOU Season 2 Makes Changes, But Part II "DNA Is In There" Along with the news of some major additions to the hit HBO series' cast, Mazin and Druckmann spoke with Variety this past week on a wide ...
Gemini 2.5 Pro supports extensive queries and deep contextual understanding. As OpenAI imposed restrictions on ChatGPT’s image generation, users turned to Grok AI, xAI's text-to-image model ...
It is now moving forward with a so-called phase 2, entailing talks with companies including state-controlled defence and aerospace group Leonardo, which will be involved in manufacturing and ...
MetaVia (MTVA) announced positive results from the 4-week multiple ascending dose Part 2 of its Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin analog agonist that functions as a ...
POTOMAC, MD / ACCESS Newswire / April 1, 2025 / IGC Pharma, Inc. (NYSE American:IGC) today announced the expansion of its Phase 2 clinical trial, CALMA, evaluating IGC-AD1 for the treatment of ...
(RTTNews) - Compass Therapeutics, Inc (CMPX), Tuesday announced promising top-line results from its Phase 2/3 COMPANION-002 trial, evaluating tovecimig, formerly CTX-009 combined with paclitaxel ...
PROVO, Utah (KUTV) — Brooke Jackson, the mother of victim Hunter Jackson, took the stand to describe the horrific crash scene that claimed the lives of her son and his best friend, Odin Ratliff ...
OpenAI’s new image generator, powered by its GPT-4o model, is now available to all users, CEO Sam Altman said in a post on X. The feature was until now available only to paying users of ChatGPT.
Avidity Biosciences (RNA) announced the completion of enrollment in the biomarker cohort in the Phase 1/2 Fortitude clinical trial of delpacibart braxlosiran in people living with ...
The images are a "unique means" of promoting dialog between science and society, she continued. This is more necessary today than ever before. 16 works were specially honored by the jury.